AR114693A1 - Vacunas contra infecciones intraabdominales - Google Patents

Vacunas contra infecciones intraabdominales

Info

Publication number
AR114693A1
AR114693A1 ARP190100615A ARP190100615A AR114693A1 AR 114693 A1 AR114693 A1 AR 114693A1 AR P190100615 A ARP190100615 A AR P190100615A AR P190100615 A ARP190100615 A AR P190100615A AR 114693 A1 AR114693 A1 AR 114693A1
Authority
AR
Argentina
Prior art keywords
vaccines against
intraabdominal infections
coli
compositions
intraabdominal
Prior art date
Application number
ARP190100615A
Other languages
English (en)
Inventor
Jan Theunis Poolman
Original Assignee
Janssen Pharmaceuticals Inc
Janssen Vaccines & Prevention Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Janssen Vaccines & Prevention Bv filed Critical Janssen Pharmaceuticals Inc
Publication of AR114693A1 publication Critical patent/AR114693A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones y métodos para vacunar contra infecciones intraabdominales provocadas por E. coli. Las composiciones comprenden un polipéptido FimH, uno o más conjugados que comprenden polisacárido de antígenos de E. coli unidos en forma covalente a una proteína transportadora y un adyuvante.
ARP190100615A 2018-03-12 2019-03-12 Vacunas contra infecciones intraabdominales AR114693A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18161252 2018-03-12

Publications (1)

Publication Number Publication Date
AR114693A1 true AR114693A1 (es) 2020-10-07

Family

ID=61832242

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100615A AR114693A1 (es) 2018-03-12 2019-03-12 Vacunas contra infecciones intraabdominales

Country Status (1)

Country Link
AR (1) AR114693A1 (es)

Similar Documents

Publication Publication Date Title
CO2018010458A2 (es) Composiciones y anticuerpos anti-tim-3
PE20190207A1 (es) Composiciones que comprenden cepas bacterianas
CY1121535T1 (el) Πρωτεϊνικα κατασκευασματα uspa2 και χρησεις αυτων
AR105470A1 (es) Métodos para inducir una respuesta inmune
BR112016016580A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados dos mesmos
EA201691478A1 (ru) Новый полисахарид и его применения
EA201790294A1 (ru) Средства на основе флагеллина и применения, включающие эффективную вакцинацию
MX2016012124A (es) Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos.
BR112017001588A2 (pt) conjugados de anticorpo/fármaco anti-cdh6
BR112016025291A2 (pt) conjugados de anticorpo anti-ptk7-fármaco
CL2016002667A1 (es) Anticuerpos anti-rnf43 novedosos y métodos para su uso
CO2021004456A2 (es) Vacunas neumocócicas multivalentes
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
BR112017011478A2 (pt) composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
MX2019004690A (es) Constructos de anticuerpos.
CO2019003949A2 (es) Formulaciones de vacunas de glicoconjugados de expec
EA202091690A1 (ru) Иммуногенная композиция, содержащая стафилококковые антигены
PE20211095A1 (es) Composiciones de escherichia coli y metodos de estas
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
CL2021000855A1 (es) Replicones basados en alfavirus para la administración de bioterapias.
EA201990451A1 (ru) Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применение
BR112017005272A2 (pt) uso de cisteamina no tratamento de infecções causadas por leveduras/bolores
EA201591808A1 (ru) Композиции и способы лечения грибковых и бактериальных патогенов
BR112016015078A2 (pt) método para prevenir ou tratar infecção por vírus influenza a h7n9, uso do anticorpo e composição farmacêutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure